17.45
price down icon1.25%   -0.22
pre-market  Pre-market:  19.10   1.65   +9.46%
loading

Cadrenal Therapeutics Inc Stock (CVKD) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
38.91%
1.7556
1.2638 1.1426 1.0262 4.2002
Operating Income/Loss
38.91%
-1.7556
-1.2638 -1.1426 -1.0262 -4.2002
Nonoperating Income/Loss
22.91%
0.0923
0.1198 0.1061 0.0232 -0.9733
Income/Loss From Continuing Operations Before Tax
45.38%
-1.6633
-1.1441 -1.0365 -1.003 -5.1736
Income/Loss From Continuing Operations After Tax
45.38%
-1.6633
-1.1441 -1.0365 -1.003 -5.1736
Net Income/Loss
45.38%
-1.6633
-1.1441 -1.0365 -1.003 -5.1736
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - -1.003 -5.1736
Basic Average Shares
1,781%
16.01
0.8512 15.40 11.72 10.77
Diluted Average Shares
1,781%
16.01
0.8512 15.40 11.72 10.77
Basic Earnings Per Share
100.00%
-0.10
-0.05 -0.07 -0.09 -0.48
Diluted Earnings Per Share
100.00%
-0.10
-0.05 -0.07 -0.09 -0.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):